Abstract:CONTEXT: Prenylated caged xanthones are "privileged structure" characterized by the presence of the unusual 4-oxo-tricyclo[4.3.1.0(3,7)]dec-8-en-2-one scaffold. The natural sources of these compounds confines mainly in the Garcinia genus in the family of Guttiferae. Gambogic acid is the most abundant substance and most of the studies have been done on this compound, particularly as a new potential antitumor agent. The history, sources, structural diversity, and biological activities of these compounds are covered.OBJECTIVE: This review is written with the intention to provide additional aspects from what have been published of prenylated caged xanthones, including history, sources, structural diversity, and biological activities.METHODS: This review has been compiled using information from a number of reliable references mainly from major databases including SciFinder, ScienceDirect, and PubMed.RESULTS: More than 120 prenylated caged xanthones have been found in the plant genera Garcinia, Cratoxylum, and Dascymaschalon. These compounds exhibited various potentially useful biological activities such as anticancer, anti-HIV-1, antibacterial, anti-inflammatory, and neurotrophic activities.CONCLUSIONS: Prenylated caged xanthones, both naturally occurring and synthetic analogues, have been identified as promising bioactive compounds, especially for anticancer agents. Gambogic acid has been demonstrated to be a highly valuable lead compound for antitumor chemotherapy. The structure activity relationship (SAR) study of its analogues is still the subject of intensive research. Apoptosis cytotoxic mechanism has been identified as the major pathway. Research on the delineation of the in-depth mechanism of action is still on-going. Analogues of gambogic acid had been identified to be effective against a rare and special form of liver cancer, cholangiocarcinoma for which currently there is no chemotherapeutic treatment available.

ChemInform Abstract: Griffipavixanthone, a Novel Cytotoxic Bixanthone from Garcinia Griffithii and G. Pavifolia.

Griffipavixanthone, a novel cytotoxic bixanthone from Garcinia griffithii and G. pavifolia

ChemInform Abstract: Lateriflorone, a Cytotoxic Spiroxalactone with a Novel Skeleton, from Garcinia Lateriflora Bl.

ChemInform Abstract: A Highly Rearranged Pentaprenylxanthonoid from the Resin of Garcinia Hanburyi.

Novel cytotoxic polyprenylated xanthonoids from Garcinia gaudichaudii (Guttiferae)

Cytotoxic Caged Tetraprenylated Xanthonoids from Garcinia Gaudichaudii (Guttiferae)

Cytotoxic Xanthone Derivatives from the Twigs of Garcinia Oligantha

Cytotoxic 7‐Methoxylated Caged Xanthones from the Twigs of Garcinia oligantha

Garcinia Xanthones As Orally Active Antitumor Agents

Caged Xanthones and Biphenyls Isolated from the Tropical Plant Garcinia lateriflora

ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

Bioactive scalemic caged xanthones from the leaves of Garcinia bracteata.

Cytotoxic Xanthone Derivatives from the Mangrove-Derived Endophytic Fungus Peniophora incarnata Z4

Xanthone Derivatives from the Leaves of Garcinia Oligantha.

ChemInform Abstract: A Novel Synthesis of the Dibenz(b,f)oxepin Ring System: 10,11‐dihydro‐ 11‐Hydroxydibenz(b,f)oxepin‐10(11h)‐one.

ChemInform Abstract: A New Cytotoxic, Apoptosis‐Inducing Triterpenoid from the Rhizomes of Astilbe Chinensis.

Cytotoxic Polyprenylated Xanthones from the Resin of Garcinia Hanburyi

A new bixanthone derivative from the bark of Garcinia oblongifolia.

Prenylated caged xanthones: Chemistry and biology

ChemInform Abstract: Phenolic Glycosides from Viburnum Fordiae Hance and Their Antioxidant Activities

Cytotoxic Prenylated Xanthones from the Leaves of Garcinia Bracteata